UBR7 and pancreatic neoplasm: In conclusion, we found that UBR7 is depleted in gemcitabine-resistant PDAC and further found that depleted UBR7 stabilizes PRMT5 to increase pancreatic cancer cell and Treg cell glycolysis, leading to pancreatic cancer progression and an immunosuppressive microenvironment.